Cytovance Biologics is a biopharmaceutical CDMO based in Oklahoma City, USA, specializing in the production of therapeutic proteins and antibodies from both mammalian and microbial expression systems. The company recently expanded its services to include in-house formulation development and pDNA production for gene therapy developers. Cytovance is FDA-registered with 2 inspections (NAI and VAI) and celebrates over 20 years in operation.
Mammalian cell culture, microbial expression, monoclonal antibody production, plasmid DNA (pDNA) production, formulation development
1 site worldwide
No reviews available yet.
No documents available.